Full-Time

HCP Promotions Senior Marketing Manager

Cardiovascular

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

Compensation Overview

$156.4k - $184.4k/yr

+ Bonus + Stock-based long-term incentives

Senior

Thousand Oaks, CA, USA

Category
General Marketing
Growth & Marketing
Required Skills
Market Research
Marketing
Requirements
  • Doctorate degree and 2 years of Marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
  • Master’s degree and 4 years of Marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
  • Bachelor’s degree and 6 years of Marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
  • Associate’s Degree and 10 years of Marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
  • High school diploma / GED and 12 years of Marketing and/or business experience in a role aligned with a Marketing/Sales commercial organization
Responsibilities
  • Co-lead overarching PCP strategy and execution to ensure that brand/business objectives are met across branded and disease state education initiatives
  • Orchestrate content development aligning with insights and overall accountability for breakthrough creative assets, from brief to launch, including collaboration with field team for feedback and input
  • Design and execute innovative health care professional promotional initiatives and tactics in alignment with brand strategic imperatives
  • Helping to guide strategic decisions and ensuring flawless execution of promotional campaigns and programs for PCPs
  • Developing promotional messages, programs and sales force tools for PCPs (which may include visual aids, emails, speaker programs and congress materials)
  • Work with Commercial Insights team to develop measurement plans and drive market research for materials and initiatives
  • Coordinating the work of multiple external vendors and internal departments including marketing, market research, legal, regulatory, medical affairs, segment marketing, corporate compliance, and consumer marketing ensuring responsible and effective communications
  • Leading projects through the legal, regulatory, and medical review process
  • Managing program budgets and developing metrics to ensure success of the promotional programs
  • Engage with Key Opinion Leaders and the global marketing team to inform creation and flawless roll out of high impact, high value marketing tools
  • Collaborate with sales training to ensure effective, impactful, world class training on promotional tools and programs
Desired Qualifications
  • Strong marketing acumen with a solid grasp of marketing strategy, market research, segmentation, brand positioning, and tactical plan development.
  • Translating market research into effective consumer campaigns or programs. Previous experience with clinical data a plus.
  • Exhibiting passion and empathy to build meaningful experiences with HCPs by understanding their needs and desires.
  • Strong bias for action and ability to manage multiple priorities in a fast-paced environment.
  • Ability to exercise strong judgment and live up to the highest ethical standards.
  • Excellent communication skills and self-awareness of leadership style
  • Ability to build productive partnerships and collaborate effectively in a matrix organization.
  • Experience coaching and developing talent

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a significant portion of its earnings to discover new therapies. The goal of Amgen is to improve patient care by providing effective therapeutic solutions and expanding its pipeline of potential new treatments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Amgen's investment in AI aligns with trends in biotechnology innovation.
  • Institutional investments indicate strong market confidence in Amgen's growth.
  • FTC clearance of the Horizon merger may ease future regulatory hurdles.

What critics are saying

  • Competitors' AI-driven drug discovery could outpace Amgen's traditional R&D methods.
  • FTC scrutiny of mergers may complicate Amgen's future growth strategy.
  • Advancements in quantum technologies could pose a competitive threat to Amgen.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline of potential new therapies in development.
  • Amgen's acquisition of Horizon Therapeutics enhances its rare disease portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.

BioSpace
Sep 19th, 2023
Amgen-Horizon Merger Clearance a Setback to FTC’s Antitrust Enforcement Plans

The consent agreement struck between the FTC and Amgen and Horizon Therapeutics could have significant implications for ongoing and future M&A challenges, experts told BioSpace.